New digital health app leads the way toward a fully autonomous
artificial pancreas system – dramatically improving the quality of life
for people with Type 1 Diabetes
SAN FRANCISCO–(BUSINESS WIRE)–Klue,
a digital health company focused on behavior tracking and positive
change, announces its platform’s expansion to Type 1 Diabetes (T1D).
Klue is already known for its gesture sensing and analytics technology
that promotes mindful eating and proper hydration. Now, it is ready to
branch out in diabetes.
Leveraging patented technology to create never-seen-before capabilities
in the realm of treating T1D, Klue’s software unlocks solutions that
will be life-changing for patients who have had a lifetime of daily
injections and blood sugar monitoring.
Intuitive and proactive, Klue’s fine motor artificial intelligence
technology detects high impact moments and allows individuals to better
manage their health, all based on insights that are captured
automatically and non-intrusively from analyzing their wrist movements.
Klue then coaches and engages users around those “in-the-moment” events,
for example by sending them bolus reminders. Klue’s early meal detection
capabilities and unique insights into eating behaviors are critical
components towards the realization of the holy grail; fully autonomous
artificial pancreas systems.
Klue invites companies, researchers and developers in the T1D space to
make use of its groundbreaking autonomous meal detection capabilities
and unique insights into user eating behaviors to roll out new,
innovative solutions. Its platform APIs allow seamless integration with
third-party applications and platforms.
With its expansion into the T1D arena, Klue is adding a mealtime
medication reminder to its suite of turnkey engagement modules. “We are
here to help people live healthier and happier lives. We believe that
the future of healthcare delivery will thrive on personal, in-the-moment
interactions centered around times of high impact,” says Katelijn
Vleugels, Founder and CEO of Klue. “The introduction of a reminder
module for mealtime insulin administration is another important step in
the realization of that vision.”
The module, specifically designed for individuals with T1D, works
seamlessly with hardware such as the Apple Watch. The module also
features automated text messaging, keeping caregivers connected and
offering peace of mind for loved ones who are concerned.
“I am excited about the potential of Klue’s early meal detection
capabilities to advance Type 1 Diabetes research and reduce the burden
of diabetes,” says Dr. Marc Breton, Associate Professor at the UVA
Center for Diabetes Technology. “Missed pre-meal insulin boluses are a
leading contributor to poor glycemic control and Klue’s real-time
detection could be beneficial to many people with type 1 diabetes. I am
most excited about the prospect of using Klue’s technology within a
fully autonomous closed-loop artificial pancreas system. Automated
real-time information of a patient’s eating behavior, coupled with novel
control algorithms, may very well enable a true ‘set and forget’ closed
loop insulin delivery system. This would be a game changer in decreasing
the daily burden of diabetes and achieving optimal glycemic control for
people with T1D.”
Klue will be showcasing its new offering at 3:30 pm on November 2 at the
2018 DiabetesMine™ D-Data ExChange — a meeting of phenomenal minds
focused on fostering and accelerating tech-forward solutions for T1D.
Individuals with Type 1 diabetes are invited to try out their new bolus
reminder module in the Klue Health App for the Apple watch ahead
of general availability! Interested? You can sign up here https://goklue.com/t1d.
Trial spots are limited and are offered on a first come, first serve
Klue is a technology company developing a groundbreaking operating
system for behavior change. Initially focused on the ability to detect
when and how a user eats and drinks, Klue is building a platform that
elevates the more important consumption patterns and enables partners to
create more insightful, real-time engagements that enhance the outcomes
of their existing paradigms. For more information, please visit http://goklue.com/.